BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

614 related articles for article (PubMed ID: 26019015)

  • 1. Hydrogen Sulfide Ameliorates Homocysteine-Induced Alzheimer's Disease-Like Pathology, Blood-Brain Barrier Disruption, and Synaptic Disorder.
    Kamat PK; Kyles P; Kalani A; Tyagi N
    Mol Neurobiol; 2016 May; 53(4):2451-2467. PubMed ID: 26019015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrogen sulfide attenuates neurodegeneration and neurovascular dysfunction induced by intracerebral-administered homocysteine in mice.
    Kamat PK; Kalani A; Givvimani S; Sathnur PB; Tyagi SC; Tyagi N
    Neuroscience; 2013 Nov; 252():302-19. PubMed ID: 23912038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ablation of MMP9 gene ameliorates paracellular permeability and fibrinogen-amyloid beta complex formation during hyperhomocysteinemia.
    Muradashvili N; Tyagi R; Metreveli N; Tyagi SC; Lominadze D
    J Cereb Blood Flow Metab; 2014 Sep; 34(9):1472-82. PubMed ID: 24865997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrogen sulfide attenuates homocysteine-induced cognitive deficits and neurochemical alterations by improving endogenous hydrogen sulfide levels.
    Kumar M; Modi M; Sandhir R
    Biofactors; 2017 May; 43(3):434-450. PubMed ID: 28394038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperhomocysteinemia increases permeability of the blood-brain barrier by NMDA receptor-dependent regulation of adherens and tight junctions.
    Beard RS; Reynolds JJ; Bearden SE
    Blood; 2011 Aug; 118(7):2007-14. PubMed ID: 21705496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GABAA receptor agonist mitigates homocysteine-induced cerebrovascular remodeling in knockout mice.
    Kumar M; Tyagi N; Moshal KS; Sen U; Pushpakumar SB; Vacek T; Lominadze D; Tyagi SC
    Brain Res; 2008 Jul; 1221():147-53. PubMed ID: 18547546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MMP-9- and NMDA receptor-mediated mechanism of diabetic renovascular remodeling and kidney dysfunction: hydrogen sulfide is a key modulator.
    Kundu S; Pushpakumar S; Sen U
    Nitric Oxide; 2015 Apr; 46():172-85. PubMed ID: 25659756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homocysteine Triggers Inflammatory Responses in Macrophages through Inhibiting CSE-H2S Signaling via DNA Hypermethylation of CSE Promoter.
    Li JJ; Li Q; Du HP; Wang YL; You SJ; Wang F; Xu XS; Cheng J; Cao YJ; Liu CF; Hu LF
    Int J Mol Sci; 2015 Jun; 16(6):12560-77. PubMed ID: 26047341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrogen Sulfide Epigenetically Attenuates Homocysteine-Induced Mitochondrial Toxicity Mediated Through NMDA Receptor in Mouse Brain Endothelial (bEnd3) Cells.
    Kamat PK; Kalani A; Tyagi SC; Tyagi N
    J Cell Physiol; 2015 Feb; 230(2):378-94. PubMed ID: 25056869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homocysteine alters cerebral microvascular integrity and causes remodeling by antagonizing GABA-A receptor.
    Lominadze D; Tyagi N; Sen U; Ovechkin A; Tyagi SC
    Mol Cell Biochem; 2012 Dec; 371(1-2):89-96. PubMed ID: 22886392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of hydrogen sulfide and homocysteine transsulfuration pathway in the progression of kidney fibrosis after ureteral obstruction.
    Jung KJ; Jang HS; Kim JI; Han SJ; Park JW; Park KM
    Biochim Biophys Acta; 2013 Dec; 1832(12):1989-97. PubMed ID: 23846016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased endogenous H2S generation by CBS, CSE, and 3MST gene therapy improves ex vivo renovascular relaxation in hyperhomocysteinemia.
    Sen U; Sathnur PB; Kundu S; Givvimani S; Coley DM; Mishra PK; Qipshidze N; Tyagi N; Metreveli N; Tyagi SC
    Am J Physiol Cell Physiol; 2012 Jul; 303(1):C41-51. PubMed ID: 22517358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homocysteine, hydrogen sulfide (H2S) and NMDA-receptor in heart failure.
    Tyagi N; Mishra PK; Tyagi SC
    Indian J Biochem Biophys; 2009 Dec; 46(6):441-6. PubMed ID: 20361707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrogen sulfide ameliorates hyperhomocysteinemia-associated chronic renal failure.
    Sen U; Basu P; Abe OA; Givvimani S; Tyagi N; Metreveli N; Shah KS; Passmore JC; Tyagi SC
    Am J Physiol Renal Physiol; 2009 Aug; 297(2):F410-9. PubMed ID: 19474193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulation of cystathionine γ-lyase (CSE)/hydrogen sulfide pathway contributes to ox-LDL-induced inflammation in macrophage.
    Wang XH; Wang F; You SJ; Cao YJ; Cao LD; Han Q; Liu CF; Hu LF
    Cell Signal; 2013 Nov; 25(11):2255-62. PubMed ID: 23872072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrogen sulfide inhibits myocardial injury induced by homocysteine in rats.
    Chang L; Geng B; Yu F; Zhao J; Jiang H; Du J; Tang C
    Amino Acids; 2008 May; 34(4):573-85. PubMed ID: 18071843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabotropic glutamate receptor 5 mediates phosphorylation of vascular endothelial cadherin and nuclear localization of β-catenin in response to homocysteine.
    Beard RS; Reynolds JJ; Bearden SE
    Vascul Pharmacol; 2012; 56(3-4):159-67. PubMed ID: 22285407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of hydrogen sulfide in early blood-brain barrier disruption following transient focal cerebral ischemia.
    Jiang Z; Li C; Manuel ML; Yuan S; Kevil CG; McCarter KD; Lu W; Sun H
    PLoS One; 2015; 10(2):e0117982. PubMed ID: 25695633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrogen sulfide mitigates matrix metalloproteinase-9 activity and neurovascular permeability in hyperhomocysteinemic mice.
    Tyagi N; Givvimani S; Qipshidze N; Kundu S; Kapoor S; Vacek JC; Tyagi SC
    Neurochem Int; 2010 Jan; 56(2):301-7. PubMed ID: 19913585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of hydrogen sulfide in secondary neuronal injury.
    Wang JF; Li Y; Song JN; Pang HG
    Neurochem Int; 2014 Jan; 64():37-47. PubMed ID: 24239876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.